Canada issues SLN (sentinel lymph node) breast biopsy guidance
This article was originally published in Clinica
Positive sentinel lymph node (SLN) biopsy results should prompt full axillary dissection, says Canada's steering committee for the care and treatment of breast cancer, in its latest guidance on SLN biopsy. Among the committee's nine recommendations are calls for SLN biopsy not to be carried out in women with clinically palpable nodes, locally advanced breast cancer, multifocal tumours, previous breast surgery or previous irradiation of the breast.
You may also be interested in...
Second read-out maintains 94% level of efficacy, with a very early signal that it could outperform Pfizer’s rival mRNA candidate in preventing severe cases.
The French major and Regeneron have racked up another indication for Dupixent with the blockbuster getting approval in Europe to treat children with severe eczema.
Russia says it will make the first deliveries of its $10-per-dose Sputnik V vaccine in January, while international regulators say vaccine trials should continue for as long as possible to generate longer-term evidence on their benefits and risks. A UK research body has stressed that drugs repurposed for COVID-19 also need to undergo thorough safety and efficacy testing as reports suggest the UK regulator could approve a vaccine within days.